ESC 365 - Panel Discussion: The case for combination therapy: The way forward in intensive LDL-c management?

Open Access

Panel Discussion: The case for combination therapy: The way forward in intensive LDL-c management?

Session: Redefining intensive LDL-c management in high risk patients: The case for combination therapy

Topic: Risk Factors and Prevention

Speaker: Professor J. Kastelein (Amsterdam, NL)

Sponsored by PACE-CME

Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

Add to my library

About the speaker

Professor John Kastelein

Faculty of Medecine - University of Amsterdam, Amsterdam (Netherlands (The))

34 presentations

6 followers

3 more presentations in this session

LDL-c in the management of high CV risk: Changing the paradigm for prevention.

Speaker: Professor K. Ray (London, GB)

The urgency to treat LDL-c post MI: The role of PCSK9 mAbs in reaching goals.

Speaker: Professor D. Connolly (Birmingham, GB)

Expanding therapeutic options for lowering LDL-c: Where will bempedoic acid and inclisiran contribute.

Speaker: Doctor C. Ballantyne (Houston, US)

Access the full session

Redefining intensive LDL-c management in high risk patients: The case for combination therapy

Speakers: Professor J. Kastelein, Professor K. Ray, Professor D. Connolly, Doctor C. Ballantyne

About the event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources